{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:40:07Z","timestamp":1726245607986},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2002,4,5]],"date-time":"2002-04-05T00:00:00Z","timestamp":1017964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/1471-2393-2-3","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:42:27Z","timestamp":1034361747000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women"],"prefix":"10.1186","volume":"2","author":[{"given":"Dulce Mar\u00eda","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Josefa E","family":"Vargas-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro A","family":"Nava-Ocampo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Palma-Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Sumano-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,4,5]]},"reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-199819010-00001","volume":"19","author":"S Olsson","year":"1998","unstructured":"Olsson S: The role of the WHO program on International Drug Monitoring in coordinating wolrdwide drug safety efforts. Drug Saf. 1998, 19: 1-10.","journal-title":"Drug Saf"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998, 279: 1200-1205. 10.1001\/jama.279.15.1200.","journal-title":"JAMA"},{"key":"11_CR3","first-page":"137","volume":"55","author":"B Detournay","year":"2000","unstructured":"Detournay B, Fagnani F, Ouyanne P, Haramburu F, Begaud B, Welsch M, Imbs JL: Cost of hospitalizations related to side-effects drugs (in French). Th\u00e9rapie. 2000, 55: 137-139.","journal-title":"Th\u00e9rapie"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","volume":"277","author":"DC Classen","year":"1997","unstructured":"Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP: Adverse drug events in hospitalized patients. Excess lenght of stay, extra costs, aand attributable mortality. JAMA. 1997, 277: 301-306. 10.1001\/jama.277.4.301.","journal-title":"JAMA"},{"key":"11_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/clinchem\/44.2.415","volume":"44","author":"PD Walson","year":"1998","unstructured":"Walson PD: Therapeutic drug monitoring in special populations. Clin Chem. 1998, 44: 415-419.","journal-title":"Clin Chem"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1073-4449(98)70012-3","volume":"5","author":"FZ Ghandour","year":"1998","unstructured":"Ghandour FZ, Knauss TC, Hricik DE: Immunosuppressive drugs in pregnancy. Adv Ren Replace Ther. 1998, 5: 31-37.","journal-title":"Adv Ren Replace Ther"},{"key":"11_CR7","first-page":"13","volume-title":"M\u00e9xico DF, Secretar\u00eda de Salud,","author":"MC Becerril-Mart\u00e9nez","year":"1995","unstructured":"Becerril-Mart\u00e9nez MC, D\u00edaz-Mart\u00e9nez A, Bondani-Guasti A: Introducci\u00f3n a la farmacovigilancia. M\u00e9xico DF, Secretar\u00eda de Salud,. 1995, 13-14."},{"key":"11_CR8","unstructured":"Instituto Nacional de Estad\u00edstica, Geograf\u00eda e Inform\u00e1tica: XII Censo General de Poblaci\u00f3n y Vivienda 2000: S\u00edntesis de Resultados. IAEGI: Estados Unidos Mexicanos. [http:\/\/www.inegi.gob.mx]"},{"key":"11_CR9","first-page":"25","volume":"1","author":"Secretar\u00eda de Salud, Direcci\u00f3n General de Estad\u00edstica e Inform\u00e1tica del Sistema Nacional de Salud, Sistema Sectorial de Informaci\u00f3n en Salud","year":"1997","unstructured":"Secretar\u00eda de Salud, Direcci\u00f3n General de Estad\u00edstica e Inform\u00e1tica del Sistema Nacional de Salud, Sistema Sectorial de Informaci\u00f3n en Salud: Principales servicios de hospitalizaci\u00f3n por instituci\u00f3n de salud. Bol Inform Estad. 1997, 1: 25-43.","journal-title":"Bol Inform Estad"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1056\/NEJM199102073240604","volume":"324","author":"TA Brennan","year":"1991","unstructured":"Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, Newhouse JP, Weiler PC, Hiatt HH: Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Eng J Med. 1991, 324: 370-376.","journal-title":"N Eng J Med"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.1974.03230310023021","volume":"228","author":"GJ Caranasos","year":"1974","unstructured":"Caranasos GJ, Stewart RB, Cluff LE: Drug-induced illness leading to hospitalization. JAMA. 1974, 228: 713-717. 10.1001\/jama.228.6.713.","journal-title":"JAMA"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.1979.03300070019017","volume":"242","author":"MS Kramer","year":"1979","unstructured":"Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR: An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA. 1979, 242: 623-632. 10.1001\/jama.242.7.623.","journal-title":"JAMA"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/jama.1979.03300070029018","volume":"242","author":"TA Hutchinson","year":"1979","unstructured":"Hutchinson TA, Leventhal JM, Kramer MS, Karch FE, Lipman AG, Feinstein AR: An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. JAMA. 1979, 242: 633-638. 10.1001\/jama.242.7.633.","journal-title":"JAMA"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1001\/jama.1979.03300180035028","volume":"242","author":"JM Leventhal","year":"1979","unstructured":"Leventhal JM, Hutchinson TA, Kramer MS, Feinstein AR: An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians. JAMA. 1979, 242: 1991-1994. 10.1001\/jama.242.18.1991.","journal-title":"JAMA"},{"key":"11_CR15","first-page":"421","volume":"34","author":"J Vargas-Rivera","year":"1996","unstructured":"Vargas-Rivera J, Hern\u00e1ndez HDM, Sumano LH, Palma AA, Bondani GA, Ponce MH: Reacciones adversas a los medicamentos en pacientes pedi\u00e1tricos en dos hospitales de segundo nivel. Rev Med IMSS. 1996, 34: 421-427.","journal-title":"Rev Med IMSS"},{"key":"11_CR16","first-page":"104","volume-title":"New York, Oxford University Press","author":"MJ Elwood","year":"1998","unstructured":"Elwood MJ: Critical appraisal od epidemiological studies and clinical trials. New York, Oxford University Press. 1998, 104-108."},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics. 1977, 33: 159-174.","journal-title":"Biometrics"},{"key":"11_CR18","first-page":"147","volume-title":"In: Phncipios de epidemiolog\u00eda de los medicamentos","author":"D Capell\u00e1","year":"1993","unstructured":"Capell\u00e1 D, Laporte JR: Spontaneous notification of adverse drug reactions (in Spanish). In: Phncipios de epidemiolog\u00eda de los medicamentos. Edited by: Laporte JR, Tognoni G. 1993, Barcelona, Ediciones cient\u00edficas y t\u00e9cnicas SA, 147-170."},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2165\/00002018-199819030-00001","volume":"19","author":"J Venulet","year":"1998","unstructured":"Venulet J, Bankowski Z: Harmonising adverse drug reaction terminology: the role of the Council for International Organizations of Medical Sciences. Drug Saf. 1998, 19: 165-172.","journal-title":"Drug Saf"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2165\/00002018-199717060-00004","volume":"17","author":"RH Meyboom","year":"1997","unstructured":"Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR: Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf. 1997, 17: 374-389.","journal-title":"Drug Saf"},{"key":"11_CR21","first-page":"653","volume":"147","author":"L Mariani","year":"1996","unstructured":"Mariani L, Minora T, Ventresca GP: Drug surveillance and adverse reactions to drugs. The literature and importance of historical data (in Italian). Clin Ter. 1996, 147: 653-672.","journal-title":"Clin Ter"},{"key":"11_CR22","first-page":"219","volume":"149","author":"L Mariani","year":"1998","unstructured":"Mariani L: Pharmacovigilance: education and continuing updating. The role of university institutes (in Italian). Clin Ter. 1998, 149: 219-225.","journal-title":"Clin Ter"},{"key":"11_CR23","first-page":"4","volume":"95","author":"PA Thurmann","year":"2000","unstructured":"Thurmann PA, Schmitt K: Detection and evaluation of adverse drug effects (in German). Med Klin. 2000, 95: 4-8.","journal-title":"Med Klin"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-2125.1998.00817.x","volume":"46","author":"RM Martin","year":"1998","unstructured":"Martin RM, Biswas PN, Freemantle SN, Pearce GL, Mann RD: Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol. 1998, 46: 505-511. 10.1046\/j.1365-2125.1998.00817.x.","journal-title":"Br J Clin Pharmacol"},{"key":"11_CR25","first-page":"254","volume":"128","author":"C Ciorciaro","year":"1998","unstructured":"Ciorciaro C, Hartmann K, Kuhn M: Differences in the relative incidence of adverse drug reactions in relation to age? An evaluation of the spontaneous reporting system of SANZ (Swiss Drug Monitoring Center) (in German). Schweiz Med Wochenschr. 1998, 128: 254-258.","journal-title":"Schweiz Med Wochenschr"},{"key":"11_CR26","first-page":"92","volume":"111","author":"MJ Mu\u00f1oz","year":"1998","unstructured":"Mu\u00f1oz MJ, Ayani I, Rodriguez-Sasiain JM, Guti\u00e9rrez G, Aguirre C: Adverse drug reaction surveillance in pediatric and adult patients in an emergency room (in Spanish). Med Clin (Barc). 1998, 111: 92-98.","journal-title":"Med Clin (Barc)"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/009127009803801103","volume":"38","author":"C Tran","year":"1998","unstructured":"Tran C, Knowles SR, Liu BA, Shear NH: Gender differences in adverse drug reactions. J Clin Pharmacol. 1998, 38: 1003-1009.","journal-title":"J Clin Pharmacol"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1001\/jama.1991.03470200059035","volume":"266","author":"DC Classen","year":"1991","unstructured":"Classen DC, Pestotnik SL, Evans RS, Burke JP: Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991, 266: 2847-2851. 10.1001\/jama.266.20.2847.","journal-title":"JAMA"},{"key":"11_CR29","first-page":"16","volume":"13","author":"R Uppal","year":"2000","unstructured":"Uppal R, Jhaj R, Malhotra S: Adverse drug reactions among inpatients in a north Indian referral hospital. Natl Med J India. 2000, 13: 16-18.","journal-title":"Natl Med J India"},{"issue":"suppl","key":"11_CR30","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1097\/00006254-199811002-00001","volume":"53","author":"F Lam","year":"1998","unstructured":"Lam F, Elliott J, Jones JS, Katz M, Knuppel RA, Morrison J, Newman R, Phelan J, Willcourt R: Clinical issues surrounding the use of terbutaline sulfate for preterm labor. Obstet Gynecol Surv. 1998, 53 (suppl): S85-S95. 10.1097\/00006254-199811002-00001.","journal-title":"Obstet Gynecol Surv"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/0002-9378(95)91369-6","volume":"173","author":"KG Perry Jr","year":"1995","unstructured":"Perry KG, Morrison JC, Rust OA, Sullivan CA, Martin RW, Naef RW: Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion. Am J Obstet Gynecol. 1995, 173: 1273-1277. 10.1016\/0002-9378(95)91369-6.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0029-7844(99)00329-4","volume":"94","author":"K Gyetvai","year":"1999","unstructured":"Gyetvai K, Hannah ME, Hodnett ED, Ohisson A: Tocolytics for preterm labor: a systematic review. Obstet Gynecol. 1999, 94: 869-877. 10.1016\/S0029-7844(99)00329-4.","journal-title":"Obstet Gynecol"},{"key":"11_CR33","first-page":"CD000035","volume":"2","author":"R Kulier","year":"2000","unstructured":"Kulier R, Hofmeyr GJ: Tocolytics for suspected intrapartum fetal distress. Cochrane Database Syst Rev. 2000, 2: CD000035-","journal-title":"Cochrane Database Syst Rev"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1136\/fn.80.2.F88","volume":"80","author":"G Eisler","year":"1999","unstructured":"Eisler G, Hjertberg R, Lagercrantz H: Randomised controlled trial of effect of terbutaline before elective caesarean section on postnatal respiration and glucose homeostasis. Arch Dis Child Fetal Neonatal Ed. 1999, 80: F88-F92.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0020-7292(83)90026-7","volume":"21","author":"Z Katz","year":"1983","unstructured":"Katz Z, Lancet M, Yemini M, Mogilner BM, Feigl A, Ben-Hur H: Treatment of premature labor contractions with combined ritodrine and indomethacine. Int J Gynaecol Obstet. 1983, 21: 337-342. 10.1016\/0020-7292(83)90026-7.","journal-title":"Int J Gynaecol Obstet"},{"key":"11_CR36","first-page":"567","volume":"74","author":"WJ Morales","year":"1989","unstructured":"Morales WJ, Smith SG, Angel JL, O'Brien WF, Knuppel RA: Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol. 1989, 74: 567-572.","journal-title":"Obstet Gynecol"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1749-6632.2001.tb03804.x","volume":"943","author":"JR Challis","year":"2001","unstructured":"Challis JR, Lye SJ, Gibb W, Whittle W, Patel F, Alfaidy N: Understanding preterm labor. Ann N Y Acad Sci. 2001, 943: 225-234.","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/jmf.10.4.223.235","volume":"10","author":"T Zakar","year":"2001","unstructured":"Zakar T, Hertelendy F: Regulation of prostaglandins synthesis in the human uterus. J Matern Fetal Med. 2001, 10: 223-235.","journal-title":"J Matern Fetal Med"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0029-7844(01)01677-5","volume":"99","author":"WE Frohn","year":"2002","unstructured":"Frohn WE, Simmons S, Carlan SJ: Prostaglandin E2 gel versus misoprostol for cervical ripening in patients with premature rupture of membranes after 34 weeks. Obstet Gynecol. 2002, 99: 206-210. 10.1016\/S0029-7844(01)01677-5.","journal-title":"Obstet Gynecol"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1071-5576(01)00124-1","volume":"8","author":"JE Scott","year":"2001","unstructured":"Scott JE, Grigsby PL, Hirst JJ, Jenkin G: Inhibition of prostaglandin synthesis and its effect on uterine activity during established premature labor in sheep. J Soc Gynecol Investig. 2001, 8: 266-276. 10.1016\/S1071-5576(01)00124-1.","journal-title":"J Soc Gynecol Investig"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/00002018-199819050-00006","volume":"19","author":"M Ostensen","year":"1998","unstructured":"Ostensen M, Ramsey-Goldman R: Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?. Drug Saf. 1998, 19: 389-410.","journal-title":"Drug Saf"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"F13","DOI":"10.1136\/fn.85.1.F13","volume":"85","author":"Z Weintraub","year":"2001","unstructured":"Weintraub Z, Solovechick M, Reichman B, Rotschild A, Waisman D, Davkin O, Lusky A, Bental Y: Effect of maternal tocolysis on the incidence of severe periventricular\/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2001, 85: F13-F17. 10.1136\/fn.85.1.F13.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"11_CR43","first-page":"9","volume":"24","author":"L Cuzzolin","year":"2001","unstructured":"Cuzzolin L, Dal-Cere M, Fanos V: NSAID-induced nephrotoxicity from the fetus to the child. Drug. 2001, 24: 9-18.","journal-title":"Drug"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0924-977X(01)00102-X","volume":"11","author":"O Benesova","year":"2001","unstructured":"Benesova O, Tejkalova H, Kristofikova Z, Husek P, Nedvidkova J, Yamamotova A: Brain maldevelopment and neurobehavioural deviations in adult rats treated neonatally with indomethacin. Eur Neuropsychopharmacol. 2001, 11: 367-373. 10.1016\/S0924-977X(01)00102-X.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"suppl 2","key":"11_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-3016.2001.00012.x","volume":"15","author":"MS Kramer","year":"2001","unstructured":"Kramer MS, Goulet L, Lydon J, Seguin L, McNamara H, Dassa C, Platt RW, Chen MF, Gauthier H, Genest J, Kahn S, Libman M, Rozen R, Masse A, Miner L, Asselin G, Benjamin A, Klein J, Koren G: Socio-economic disparities in preterm birth: causal pathaways and mechanisms. Pediatr Perinatal Epidemiol. 2001, 15 (suppl 2): 104-123. 10.1046\/j.1365-3016.2001.00012.x.","journal-title":"Pediatr Perinatal Epidemiol"},{"key":"11_CR46","first-page":"477","volume":"90","author":"AO Scott-Wright","year":"1998","unstructured":"Scott-Wright AO, Wrona RM, Flanagan TM: Predictors of infant mortality among college-educated black and white women, Davidson County, Tennessee, 1990\u20131994. J Natl Med Assoc. 1998, 90: 477-483.","journal-title":"J Natl Med Assoc"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1067\/mob.2001.114869","volume":"185","author":"JA Zeitlin","year":"2001","unstructured":"Zeitlin JA, Ancel PY, Saurel-Cubizolles MJ, Papiernik E: Are risk factors the same for small for gestational age versus other preterm births?. Am J Obstet Gynecol. 2001, 185: 208-215. 10.1067\/mob.2001.114869.","journal-title":"Am J Obstet Gynecol"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00001786-199812000-00007","volume":"13","author":"GJ Arnold","year":"1998","unstructured":"Arnold GJ: Clinical recognition of adverse drug reactions: obstacles and opportunities for the nursing profession. J Nurs Care Qual. 1998, 13: 45-55.","journal-title":"J Nurs Care Qual"},{"key":"11_CR49","first-page":"52","volume":"94","author":"S Morrison-Griffiths","year":"1998","unstructured":"Morrison-Griffiths S, Pirmohamed M, Walley T: Reporting of adverse drug reactions: practice in the UK. Nurs Times. 1998, 94: 52-54.","journal-title":"Nurs Times"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-2-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-2-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-2-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-2-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:28:46Z","timestamp":1726241326000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-2-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-2-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"type":"electronic","value":"1471-2393"}],"subject":[],"published":{"date-parts":[[2002,4,5]]},"assertion":[{"value":"15 July 2001","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"3"}}